Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06610721Recruiting
Better UTI diagnosis for older adults
This trial tests a panel of markers in urine to see if it can more accurately diagnose urinary tract infections in people aged 65 and older. If successful, it could lead to faster and more precise treatment.
Leiden, South HollandAges 65 years+ - NCT06610851Recruiting
Monitoring low-grade brain tumors with a blood test
This study is looking at whether a simple blood test that checks for tiny molecules (called miRNAs) can help monitor people with slow-growing brain tumors. If you had surgery for a grade 2 or 3 glioma at Caen University Hospital and are still being followed there, this study might be for you.
CaenAges 18 years+ - NCT06610864Recruiting
Corrective surgery for womb shape issues and pregnancy outcomes
This study looks at how women with certain womb shape problems (like a septum or unusual shape) do during and after pregnancy once they have a minor surgery to fix the shape. Researchers want to see if the surgery helps improve pregnancy and birth results.
Rome, RMAges 18 years+ - NCT06611137RecruitingPhase 2
SBRT plus chemoimmunotherapy to save the voice box
This trial tests a new approach to treat advanced larynx or hypopharynx cancer without removing the voice box. First, you get targeted radiation (SBRT), then a combination of chemotherapy and an immunotherapy drug called Toripalimab, which helps your immune system fight the cancer.
Guangzhou, GuangdongAges 18–70 - NCT06611150RecruitingPhase 1
Chemo and radiation for advanced nasopharyngeal cancer
This trial tests whether a specific chemotherapy drug (nab-paclitaxel) given along with targeted radiation therapy can help people with stage III or IVa nasopharyngeal cancer. The goal is to improve treatment outcomes while managing side effects.
Guangzhou, GuangdongAges 18–70 - NCT06611618Recruiting
Predicting fall risk in knee osteoarthritis using muscle tests
This study looks at how loss of muscle strength and control in people with knee osteoarthritis can predict falls. It uses tests and MRI to understand your risk, with the goal of helping prevent future falls.
BolognaAges 65–80 - NCT06611787Recruiting
Registry study for congenital heart disease
This study collects information from people with congenital heart disease (a heart problem you're born with) over their entire life to better understand the condition and improve future care.
Beijing, Beijing MunicipalityAges Any age - NCT06612242Recruiting
Early vs. late tracheostomy in Guillain-Barre patients
This trial looks at whether having a tracheostomy (a breathing tube placed through the neck) earlier or later helps people with Guillain-Barre syndrome who need a breathing machine. It reviews past cases to see which timing leads to better recovery.
Kfar SabaAges 18 years+ - NCT06612515Recruiting
Vaccine response in patients with weak immune systems
This study looks at how well vaccines for respiratory viruses work in people with weakened immune systems. It may help doctors give better vaccine advice to patients like you.
Cologne, North Rhine-WestphaliaAges 18 years+ - NCT06612632RecruitingPhase 1/Phase 2
Retrying Immunotherapy for Solid Tumors After First Trial
This trial tests whether giving immunotherapy again can help people with solid tumors who have already tried an experimental treatment in a clinical trial and it stopped working. It looks for patients whose cancer has returned or spread and who can start the new treatment within 12 weeks of their last therapy.
BeijingAges 18 years+ - NCT06612840RecruitingPhase 1
A study of GNC-077 for advanced lung cancer and other solid tumors
This trial tests a new drug called GNC-077 for people with advanced non-small cell lung cancer or other solid tumors that have spread. It aims to see if the drug is safe and helps shrink tumors.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06612944RecruitingPhase 2
Preventing relapse after stem cell transplant for high-risk MDS
This trial tests whether giving medication after a donor stem cell transplant can prevent the return of very high-risk myelodysplastic syndrome (MDS). It is for people who have a suitable donor and are healthy enough for the procedure.
ShanghaiAges 18–70 - NCT06613074Recruiting
Smartphone app for stroke triage without ambulance
This trial is testing a smartphone app that helps guide patients with a recent stroke to the right place for care, if they did not come by ambulance. It is for people who have already received clot-busting treatment.
Shaoxing, ZhejingAges 18 years+ - NCT06613581Recruiting
Home-based follow-up after colorectal cancer surgery
This trial tests whether patients can do their follow-up from home after surgery for colorectal cancer. It uses a smartphone app instead of hospital visits, aiming to make surveillance easier and less stressful.
Breda, North BrabantAges 21 years+ - NCT06614088Recruiting
Calprotectin blood test for belly infections after surgery
This trial tests whether a blood test called calprotectin can help doctors spot infections in surgical patients with belly problems. It may help doctors decide if you need antibiotics or other treatments.
PisaAges 18 years+ - NCT06614595Recruiting
Transfusion and quality of life in lower-risk MDS
This study looks at how well transfusions work and how they affect quality of life in people with lower-risk MDS who need regular blood transfusions. The goal is to find what predicts a good transfusion response and to improve care.
Oviedo, Principality of AsturiasAges 18 years+ - NCT06614686RecruitingPhase 1
CAR-T therapy for advanced head and neck cancer
This study tests a new type of CAR-T cell therapy that targets a protein called Trop2 found on some head and neck cancer cells. It's for people who have tried standard treatments and need a new option.
ShanghaiAges 18–70 - NCT06614647Recruiting
Digital follow-up for colorectal cancer survivors
This trial tests a smartphone-based follow-up program for people who have been treated for early-stage colorectal cancer. The goal is to see if a digital, need-based care guide can replace standard follow-up visits.
Herning, Central JutlandAges 18 years+ - NCT06614790Recruiting
Niraparib maintenance for advanced ovarian cancer
This study looks at how well the drug niraparib works as a maintenance treatment for women with advanced ovarian cancer that responded well to initial platinum-based chemotherapy. It may help keep the cancer from coming back.
BialystokAges 18 years+ - NCT06614829Recruiting
C-section wound closure: standard vs. a new skin closure system
This study compares two types of wound closure after a planned C-section to see which one patients prefer and how it affects healing. It uses a special skin closure system that may reduce scarring and improve your recovery experience.
North York, OntarioAges 18 years+ - NCT06614998Recruiting
Early warning screening for hemophagocytic lymphohistiocytosis
This study aims to create an early warning system to identify patients with hemophagocytic lymphohistiocytosis (HLH), a rare but serious immune overreaction. If you have certain infections, autoimmune diseases, or lymphoma, this screening could help detect HLH early.
Xuzhou, JiangsuAges Any age - NCT06615193RecruitingPhase 1
Testing a new drug for certain blood and solid tumors
This study tests a new drug, HDM2005, for people with relapsed or hard-to-treat B-cell lymphoma or advanced solid tumors. The goal is to see if it is safe and effective.
Zhengzhou, HenanAges 18 years+ - NCT06615271Recruiting
Studying pressure injuries during and after brain surgery
This study looks at how often patients develop pressure injuries (sores from lying in one position too long) during long brain surgeries. It tracks patients before, during, and after surgery to find ways to prevent these injuries.
Santander, CantabriaAges 18–100 - NCT06615453Recruiting
Tixel treatment for dry eye disease and periorbital wrinkles
This study tests a device called Tixel that may help reduce wrinkles around the eyes and improve dry eye symptoms. If you have mild to moderate under-eye wrinkles and dry eyes that bother you a lot, this treatment might be an option.
BirminghamAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.